Tau Pathology in Chronic Traumatic Encephalopathy and Alzheimer's Disease: Similarities and Differences

Traumatic brain injury (TBI) has been associated with the development of Alzheimer's disease (AD) because these conditions share common pathological hallmarks: amyloid-β and hyperphosphorylated tau accumulation. However, given recent data it is uncertain if a history of TBI leads to the develop...

Full description

Bibliographic Details
Main Authors: Atsuko Katsumoto, Hideyuki Takeuchi, Fumiaki Tanaka
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.00980/full
_version_ 1811219015558758400
author Atsuko Katsumoto
Hideyuki Takeuchi
Fumiaki Tanaka
author_facet Atsuko Katsumoto
Hideyuki Takeuchi
Fumiaki Tanaka
author_sort Atsuko Katsumoto
collection DOAJ
description Traumatic brain injury (TBI) has been associated with the development of Alzheimer's disease (AD) because these conditions share common pathological hallmarks: amyloid-β and hyperphosphorylated tau accumulation. However, given recent data it is uncertain if a history of TBI leads to the development of AD. Moreover, chronic traumatic encephalopathy (CTE), caused by repetitive mild TBI and characterized by progressive neurodegeneration with hyperphosphorylated tau, has come to be recognized as distinct from AD. Therefore, it is important to elucidate the clinical outcomes and molecular mechanisms underlying tau pathology following TBI. We summarize the histopathological features and clinical course of TBI in CTE, comparing the tau pathology with that in AD. Following brain injury, diffuse axonal injury, and hyperphosphorylated tau aggregates are observed within a shorter period than in AD. Hyperphosphorylated tau deposition usually begins in the perivascular area of the sulci in the cerebral cortex, then spreads unevenly in the cortex in CTE, while AD shows diffuse distribution of hyperphosphorylated tau in the cortical areas. We also highlight the molecular profile of tau and the implications of tau progression throughout the brain in both diseases. Tau contains phosphorylation sites common to both conditions. In particular, phosphorylation at Thr231 triggers a conformational change to the toxic cis form of tau, which is suggested to drive neurodegeneration. Although the mechanism of rapid tau accumulation remains unknown, the structural diversity of tau might result in these different outcomes. Finally, future perspectives on CTE in terms of tau reduction are discussed.
first_indexed 2024-04-12T07:18:38Z
format Article
id doaj.art-c8e2fc8bd1ad4444b525fad795e1ee9a
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-12T07:18:38Z
publishDate 2019-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-c8e2fc8bd1ad4444b525fad795e1ee9a2022-12-22T03:42:23ZengFrontiers Media S.A.Frontiers in Neurology1664-22952019-09-011010.3389/fneur.2019.00980461345Tau Pathology in Chronic Traumatic Encephalopathy and Alzheimer's Disease: Similarities and DifferencesAtsuko KatsumotoHideyuki TakeuchiFumiaki TanakaTraumatic brain injury (TBI) has been associated with the development of Alzheimer's disease (AD) because these conditions share common pathological hallmarks: amyloid-β and hyperphosphorylated tau accumulation. However, given recent data it is uncertain if a history of TBI leads to the development of AD. Moreover, chronic traumatic encephalopathy (CTE), caused by repetitive mild TBI and characterized by progressive neurodegeneration with hyperphosphorylated tau, has come to be recognized as distinct from AD. Therefore, it is important to elucidate the clinical outcomes and molecular mechanisms underlying tau pathology following TBI. We summarize the histopathological features and clinical course of TBI in CTE, comparing the tau pathology with that in AD. Following brain injury, diffuse axonal injury, and hyperphosphorylated tau aggregates are observed within a shorter period than in AD. Hyperphosphorylated tau deposition usually begins in the perivascular area of the sulci in the cerebral cortex, then spreads unevenly in the cortex in CTE, while AD shows diffuse distribution of hyperphosphorylated tau in the cortical areas. We also highlight the molecular profile of tau and the implications of tau progression throughout the brain in both diseases. Tau contains phosphorylation sites common to both conditions. In particular, phosphorylation at Thr231 triggers a conformational change to the toxic cis form of tau, which is suggested to drive neurodegeneration. Although the mechanism of rapid tau accumulation remains unknown, the structural diversity of tau might result in these different outcomes. Finally, future perspectives on CTE in terms of tau reduction are discussed.https://www.frontiersin.org/article/10.3389/fneur.2019.00980/fulltautraumatic brain injurychronic traumatic encephalopathycis p-tauprion
spellingShingle Atsuko Katsumoto
Hideyuki Takeuchi
Fumiaki Tanaka
Tau Pathology in Chronic Traumatic Encephalopathy and Alzheimer's Disease: Similarities and Differences
Frontiers in Neurology
tau
traumatic brain injury
chronic traumatic encephalopathy
cis p-tau
prion
title Tau Pathology in Chronic Traumatic Encephalopathy and Alzheimer's Disease: Similarities and Differences
title_full Tau Pathology in Chronic Traumatic Encephalopathy and Alzheimer's Disease: Similarities and Differences
title_fullStr Tau Pathology in Chronic Traumatic Encephalopathy and Alzheimer's Disease: Similarities and Differences
title_full_unstemmed Tau Pathology in Chronic Traumatic Encephalopathy and Alzheimer's Disease: Similarities and Differences
title_short Tau Pathology in Chronic Traumatic Encephalopathy and Alzheimer's Disease: Similarities and Differences
title_sort tau pathology in chronic traumatic encephalopathy and alzheimer s disease similarities and differences
topic tau
traumatic brain injury
chronic traumatic encephalopathy
cis p-tau
prion
url https://www.frontiersin.org/article/10.3389/fneur.2019.00980/full
work_keys_str_mv AT atsukokatsumoto taupathologyinchronictraumaticencephalopathyandalzheimersdiseasesimilaritiesanddifferences
AT hideyukitakeuchi taupathologyinchronictraumaticencephalopathyandalzheimersdiseasesimilaritiesanddifferences
AT fumiakitanaka taupathologyinchronictraumaticencephalopathyandalzheimersdiseasesimilaritiesanddifferences